At a glance
- Originator Abbott Laboratories
- Class Cytostatic antibiotics; Macrolides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 Jul 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 28 Feb 1996 Preclinical development for Cancer in USA (Unknown route)